Helen H. Hobbs

Molecular Biology · 2000–2021

A researcher in the Science corpus: 23 papers; trusts 4 researchers and is trusted by 13 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 70 citations into it; #16,773 of 17,773 by trust here, #2,814 by citations
• Surgery — 58 citations into it; #160 of 1,106 by trust here, #43 by citations
• Nutrition and Dietetics — 7 citations into it

Whom Helen H. Hobbs trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Jay D. Horton
2. Jonathan C. Cohen
3. J. Breslow
4. J. Goldstein

Who trusts Helen H. Hobbs overall

1. Y. Kawano
2. V. Samuel

Papers from Helen H. Hobbs's perspective

Ordered by how strongly the researchers Helen H. Hobbs trusts endorse each paper. Same corpus, a different order for every researcher.

1. The prevalence and etiology of elevated aminotransferase levels in the United States (American Journal of Gastroenterology)
2. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.
3. Molecular mediators of hepatic steatosis and liver injury. (Journal of Clinical Investigation)
4. Clinical Features and Natural History of Nonalcoholic Steatosis Syndromes (Seminars in liver disease (Print))
5. AGA technical review on nonalcoholic fatty liver disease. (Gastroenterology)
6. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption (Nature Genetics)
7. Newly identified loci that influence lipid concentrations and risk of coronary artery disease (Nature Genetics)
8. Partition-ligation-expectation-maximization algorithm for haplotype inference with single-nucleotide polymorphisms. (American Journal of Human Genetics)
9. Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates (Proceedings of the National Academy of Sciences of the United States of America)
10. Binding of Proprotein Convertase Subtilisin/Kexin Type 9 to Epidermal Growth Factor-like Repeat A of Low Density Lipoprotein Receptor Decreases Receptor Recycling and Increases Degradation* (Journal of Biological Chemistry)

Their papers

• A Common Allele on Chromosome 9 Associated with Coronary Heart Disease (2007) — 1,486 citations
• Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. (2000) — 1,683 citations
• Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion (2002) — 785 citations
• A Sequence Variation (I148M) in PNPLA3 Associated with Nonalcoholic Fatty Liver Disease Disrupts Triglyceride Hydrolysis (2009) — 620 citations
• Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote. (2006) — 659 citations
• Autosomal Recessive Hypercholesterolemia Caused by Mutations in a Putative LDL Receptor Adaptor Protein (2001) — 622 citations
• Regulation of ATP-binding Cassette Sterol Transporters ABCG5 and ABCG8 by the Liver X Receptors α and β* (2002) — 754 citations
• Binding of Proprotein Convertase Subtilisin/Kexin Type 9 to Epidermal Growth Factor-like Repeat A of Low Density Lipoprotein Receptor Decreases Receptor Recycling and Increases Degradation* (2007) — 782 citations
• Molecular basis of cholesterol efflux via ABCG subfamily transporters (2021) — 71 citations
• A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease (2018) — 665 citations
• Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease (2014) — 1,133 citations
• Human Fatty Liver Disease: Old Questions and New Insights (2011) — 2,072 citations
• Exome Sequencing, ANGPTL3 Mutations, and Familial Combined Hypolipidemia (2010) — 742 citations
• PCSK9: a convertase that coordinates LDL catabolism Published, JLR Papers in Press, November 19, 2008. (2009) — 613 citations
• Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease (2008) — 3,244 citations
• Molecular biology of PCSK9: its role in LDL metabolism. (2007) — 613 citations
• Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. (2006) — 3,129 citations
• Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9 (2005) — 1,394 citations
• Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. (2005) — 1,593 citations
• Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity (2004) — 3,736 citations